E-cigarettes: Research, Public Health Concerns and Opportunities, and Regulations
Electronic nicotine delivery systems (ENDS), which include electronic cigarettes (e-cigarettes), have become increasingly popular among adults and youth. On Aug. 8, 2016, the U.S. Food and Drug Administration (FDA) extended the current ban on the sale of tobacco products to youth under the age of 18 years to include e-cigarettes, cigars, pipe tobacco, and waterpipe tobacco. The extended ban went into effect 90 days after the release of the FDA “deeming” rule, which makes additional tobacco products subject to the FDA’s federal regulatory authority as amended by the Family Smoking Prevention and Tobacco Control Act.
In recognition of the FDA ban on e-cigarette sales to youth, the American Association for Cancer Research (AACR) Tobacco and Cancer Subcommittee is releasing a new webinar,
“E-cigarettes: Research, Public Health Concerns and Opportunities, and Regulations,” with discussions of current research on and the public health impact of e-cigarettes. The webinar includes presentations by the FDA; Centers for Disease Control (CDC); Peter G. Shields, MD, Ohio State University; and Benjamin A. Toll, PhD, Medical University of South Carolina.